Ticagrelor vs. clopidogrel in dual antiplatelet therapy after coronary artery bypass surgery: a meta-analysis
The meta-analysis presented the evidence supporting the use of A + T post-CAVG in reducing all-cause mortality and cardiovascular mortality, with no increase in bleeding events, in comparison with A + C. Additional RCTs are needed to determine the optimal DAPT after CABG.
Authors
- Xiaochun Ma (ORCID: https://orcid.org/0000-0003-1055-4691)
- Yingying Zhao (ORCID: https://orcid.org/0000-0001-6308-4043)
- Zhengjun Wang (ORCID: https://orcid.org/0000-0003-1912-5519)
- Tao Zhang (ORCID: https://orcid.org/0000-0003-1048-4443)
- Liyuan Wang (ORCID: https://orcid.org/0000-0003-2718-6450)
- Yi-Long Lung Cancer Wu (ORCID: https://orcid.org/0000-0002-3611-0258)
- Shijie Zhang (ORCID: https://orcid.org/0000-0002-8041-0581)
- Jian Song (ORCID: https://orcid.org/0000-0003-2004-9250)
- Yun Yan (ORCID: https://orcid.org/0000-0003-2605-8860)
Institutions
- Shandong Provincial Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fcvm.2025.1542437
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province